1999CirculationOpen access

Different Cell Types Within the Sinoatrial Node

Luiz Alberto Benvenuti, Vera Demarchi Aiello, Maria de Lourdes Higuchi

Open full text 1 citations

Abstract

Unexpected Mechanism of Action of a Calcium Channel-Blocking Agent To the Editor:In a recent interesting article, 1 Zhang and Hintze stated that amlodipine but not nifedipine released nitric oxide from canine coronary microvessels and classified this as an unexpected mechanism of action.However, it should be noted that several years ago, the same phenomenon, ie, direct release of NO, was observed with nitrendipine in small porcine coronary arteries, porcine arteria basilaris, and porcine arteria caudalis.2 Similarly, the vasodilating action of nitrendipine, nifedipine, nisoldipine, and nimodipine in guinea pig mesenteric vascular beds was found to be sensitive to L-N G -nitroarginine treatment.3 The latter was more pronounced in smaller arterioles (diameter Ͻ350 m).Regarding the mechanism of action underlying the release of NO, it was shown recently by use of the fura-2 technique that the calcium antagonist nitrendipine enhances the intracellular calcium concentration in suspensions of cultured endothelial cells.4 This effect was insensitive to thapsigargin but was sensitive to extracellular depletion of calcium, indicating that the observed increase in intracellular calcium concentration was mainly due to an influx of calcium rather than a calcium release from intracellular stores.The elevation of intracellular calcium by nitrendipine could be completely blocked by application of gadolinium, a trivalent lanthanide known to inhibit shear stress-activated cation-selective channels on endothelial cells.In addition, the authors showed that the increase in intracellular [Ca 2ϩ ] by shear stress was further enhanced in the presence of nitrendipine.4 In summary, the release of NO from vascular endothelium is not unique to amlodipine but seems to be a group phenomenon of 1,4-dihydropyridines.The NO release may be more or less prominent when various substances in various vessel types are compared.As shown, the NO dependence of vasodilation by 1,4-dihydropyridines may also be influenced by the position of the vessels within the vascular tree.3 In addition, this NOreleasing action is not restricted to vascular endothelium but can also be found in platelets, as shown for nifedipine, and contributes to its antiaggregatory effects.

Open-access reader

About this research paper

What this paper is about

Unexpected Mechanism of Action of a Calcium Channel-Blocking Agent To the Editor:In a recent interesting article, 1 Zhang and Hintze stated that amlodipine but not nifedipine released nitric oxide from canine coronary microvessels and classified this as an unexpected mechanism of action.However, it should be noted that several years ago, the same phenomenon, ie, direct release of NO, was observed with nitrendipine in small porcine coronary arteries, porcine arteria basilaris, and porcine arteria caudalis.2 Similarly, the vasodilating action of nitrendipine, nifedipine, nisoldipine, and nimodipine in guinea pig mesenteric vascular beds was found to be sensitive to L-N G -nitroarginine treatment.3 The latter was more pronounced in smaller arterioles (diameter Ͻ350 m).Regarding the mechanism of action underlying the release of NO, it was shown recently by use of the fura-2 technique that the calcium antagonist nitrendipine enhances the intracellular calcium concentration in suspensions of cultured endothelial cells.4 This effect was insensitive to thapsigargin but was sensitive to extracellular depletion of calcium, indicating that the observed increase in intracellular calcium concentration was mainly due to an influx of calcium rather than a calcium release from intracellular stores.The elevation of intracellular calcium by nitrendipine could be completely blocked by application of gadolinium, a trivalent lanthanide known to inhibit shear stress-activated cation-selective channels on endothelial cells.In addition, the authors showed that the increase in intracellular [Ca 2ϩ ] by shear stress was further enhanced in the presence of nitrendipine.4 In summary, the release of NO from vascular endothelium is not unique to amlodipine but seems to be a group phenomenon of 1,4-dihydropyridines.The NO release may be more or less prominent when various substances in various vessel types are compared.As shown, the NO dependence of vasodilation by 1,4-dihydropyridines may also be influenced by the position of the vessels within the vascular tree.3 In addition, this NOreleasing action is not restricted to vascular endothelium but can also be found in platelets, as shown for nifedipine, and contributes to its antiaggregatory effects.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Unexpected Mechanism of Action of a Calcium Channel-Blocking Agent To the Editor:In a recent interesting article, 1 Zhang and Hintze stated that amlodipine but not nifedipine released nitric oxide from canine coronary microvessels and classified this as an unexpected mechanism of action.However, it should be noted that several years ago, the same phenomenon, ie, direct release of NO, was observed with nitrendipine in small porcine coronary arteries, porcine arteria basilaris, and porcine arteria caudalis.2 Similarly, the vasodilating action of nitrendipine, nifedipine, nisoldipine, and nimodipine in guinea pig mesenteric vascular beds was found to be sensitive to L-N G -nitroarginine treatment.3 The latter was more pronounced in smaller arterioles (diameter Ͻ350 m).Regarding the mechanism of action underlying the release of NO, it was shown recently by use of the fura-2 technique that the calcium antagonist nitrendipine enhances the intracellular calcium concentration in suspensions of cultured endothelial cells.4 This effect was insensitive to thapsigargin but was sensitive to extracellular depletion of calcium, indicating that the observed increase in intracellular calcium concentration was mainly due to an influx of calcium rather than a calcium release from intracellular stores.The elevation of intracellular calcium by nitrendipine could be completely blocked by application of gadolinium, a trivalent lanthanide known to inhibit shear stress-activated cation-selective channels on endothelial cells.In addition, the authors showed that the increase in intracellular [Ca 2ϩ ] by shear stress was further enhanced in the presence of nitrendipine.4 In summary, the release of NO from vascular endothelium is not unique to amlodipine but seems to be a group phenomenon of 1,4-dihydropyridines.The NO release may be more or less prominent when various substances in various vessel types are compared.As shown, the NO dependence of vasodilation by 1,4-dihydropyridines may also be influenced by the position of the vessels within the vascular tree.3 In addition, this NOreleasing action is not restricted to vascular endothelium but can also be found in platelets, as shown for nifedipine, and contributes to its antiaggregatory effects.

Key concepts: Sinoatrial node, Myocyte, Medicine, Diastolic depolarization, Internal medicine, Cardiology, Heart rate, Blood pressure

Related papers

Back to paper searchBrowse research topicsOriginal source
Different Cell Types Within the Sinoatrial Node — Research Paper | ScholarLens